Core Scientific: A Fleeting Rally

The fund, in the last quarter of the previous year, parted ways with 495,390 shares of Core Scientific. Eight and a half million dollars worth of hope, vanished into the accounts of those who always win. They retain a sliver – 74,664 shares – but the overall position shrank, a net loss of $9.14 million. It’s a quiet subtraction, a silent re-allocation of capital. A fund doesn’t weep over such numbers, but it does signal a change of heart.







